Stockreport

Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial Results

Maravai LifeSciences Holdings, Inc. - Class A common stock  (MRVI) 
PDF Organizational restructuring and operating cost reduction ahead of planFocus on operational excellence, revenue growth, and improving Adjusted EBITDA SAN DIEGO--(BUSI [Read more]